Blood disorders and cancer together represent a major global health burden. According to estimates from international health authorities, including the World Health Organization, cancer is one of the leading causes of death worldwide, while hematological conditions such as anemia, clotting disorders, leukemias, lymphomas, and bone marrow diseases affect millions of people across all age groups. Advances in diagnostics, targeted therapies, immunotherapy, and supportive care have significantly improved disease management, but they have also increased the need for highly specialized physicians trained in both hematology and oncology.
Brazil provides hematology-oncology care within a nationally regulated healthcare system that combines public academic institutions with private tertiary hospitals. Hematologists-oncologists in Brazil complete a full medical degree followed by residency training in internal medicine and further specialization in hematology, oncology, or both, depending on their clinical focus. Licensing, certification, and professional conduct are overseen by national medical councils, and clinical practice is guided by internationally recognized oncology and hematology guidelines.
Major hospitals in Brazil are equipped with modern pathology laboratories, advanced imaging, infusion centers, and multidisciplinary tumor boards. These systems support evidence-based diagnosis and treatment planning, particularly for complex cancers and blood disorders. Care pathways often involve collaboration between hematologists, medical oncologists, radiation oncologists, surgeons, pathologists, and supportive care teams.
For international patients, Brazil is sometimes considered due to its established clinical expertise and comparatively accessible consultation costs. Treatment discussions typically emphasize realistic expectations, potential risks, treatment limitations, and individual variability in response. Psychological and emotional support services are increasingly integrated into oncology care, recognizing the impact of cancer and chronic blood disorders on patients and families. Overall, Brazil’s hematology-oncology framework prioritizes safety, informed consent, and patient-centered decision-making.
Dr. Drauzio Varella, MD
Specialization: Medical oncology and public health education
Years of Experience: Over 40 years
Dr. Varella’s clinical background includes cancer care and oncology education, with a strong focus on evidence-based medicine. He has been associated with Hospital das Clínicas da USP, a major academic medical center.
Dr. Nelson Teich, MD
Specialization: Medical oncology and health systems management
Years of Experience: Over 30 years
Dr. Teich focuses on solid tumor oncology and oncology care organization. He practices at Hospital Israelita Albert Einstein, within a multidisciplinary oncology program.
Dr. Paulo Hoff, MD
Specialization: Gastrointestinal oncology
Years of Experience: Over 25 years
Dr. Hoff’s clinical work centers on colorectal and gastrointestinal cancers, with involvement in clinical research. He is affiliated with Instituto do Câncer do Estado de São Paulo (ICESP), a public tertiary cancer center.
Dr. Guilherme Bianchini, MD
Specialization: Breast oncology
Years of Experience: Over 15 years
Dr. Bianchini focuses on breast cancer management using guideline-based systemic therapies. He practices at Hospital Sírio-Libanês, within an integrated oncology service.
Dr. Carmino de Souza, MD
Specialization: Hematology and bone marrow disorders
Years of Experience: Over 35 years
Dr. Carmino specializes in hematological malignancies and bone marrow diseases. He works at Centro de Hematologia e Hemoterapia da Unicamp (Hemocentro Unicamp), an academic and research-focused institution.
Dr. Israel Bendit, MD
Specialization: Leukemia and myelodysplastic syndromes
Years of Experience: Over 30 years
Dr. Bendit’s clinical focus includes acute and chronic leukemias, with emphasis on diagnostic precision. He is associated with Hospital Israelita Albert Einstein.
Dr. Juliana Pereira, MD
Specialization: Thoracic oncology
Years of Experience: Over 15 years
Dr. Pereira specializes in lung cancer and thoracic malignancies, integrating molecular diagnostics into treatment planning. She practices at Instituto do Câncer do Estado de São Paulo (ICESP).
Dr. Eduardo Rego, MD
Specialization: Hematologic malignancies and stem cell transplantation
Years of Experience: Over 25 years
Dr. Rego focuses on complex blood cancers and transplant-related care. He is affiliated with Hospital das Clínicas da USP, working within a multidisciplinary hematology-oncology team.
| Consultation Type | Estimated Cost Range |
| Hematologists-Oncologists consultation | $200–$500 |
Note: Costs are approximate and provided for general guidance only. Prices vary by healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. The provider determines final fees after an individual clinical assessment and may be affected by currency fluctuations.
Choosing cancer or blood disorder care abroad can feel emotionally and practically challenging. Patients and families often seek clear information, careful coordination, and reassurance grounded in facts rather than promises.
➤ Availability of English-speaking medical staff and professional medical translators in many facilities
➤ Specialized clinics that manage a high volume of international patients
➤ Government regulations and oversight mechanisms supporting medical tourism safety and international patient protection
➤ Structured hospital documentation, patient-safety protocols, and informed consent practices
International patients should also consider practical aspects of care. Visa or entry requirements depend on nationality and must be confirmed in advance. Some hematology-oncology treatments may require extended stays, often 7–14 days or longer, depending on diagnostic workup or therapy schedules. English-language support is more common in major cities than in smaller regions. Planning follow-up care and coordination with healthcare providers in your home country is essential before traveling.
Patients considering hematology-oncology care in Brazil may share their medical reports with Best Clinic Abroad, a medical travel facilitator, to receive support with consultation coordination, document review, and an organized starting point for care planning.
Do you need a visa to travel to Brazil for hematology or oncology consultations?
Visa requirements depend on your nationality and the length of your stay. Some travelers may enter Brazil without a visa for short visits, while others must apply in advance. You should confirm current requirements with the Brazilian consulate before planning medical travel.
Will you be able to communicate in English with hematologists-oncologists in Brazil?
Many major cancer centers and hospitals in Brazil have English-speaking physicians or access to professional medical interpreters. Outside large urban centers, English availability may be more limited, so confirming language support ahead of time is important.
Can you arrange an online consultation before traveling to Brazil?
Yes. You can request an online consultation through Best Clinic Abroad, which helps coordinate remote consultations with licensed hematologists-oncologists in Brazil. This allows you to share medical records and discuss your condition before making travel decisions.
Are hematologists-oncologists in Brazil properly trained and regulated?
Yes. Hematologists-oncologists in Brazil complete formal medical education, residency training, and specialty certification. They are licensed by national medical councils, and hospitals operate under healthcare regulations designed to support patient safety and ethical practice.
How should you plan follow-up care after returning home?
You should arrange follow-up care with an appropriate specialist in your home country before traveling. Ongoing monitoring, supportive care, and coordination with your local healthcare team are essential parts of responsible cancer and blood disorder management.
Disclaimer
This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.